We're working on profiling this company soon. Let us know you're interested by sending us a request here »
We're working hard to bring you this company's profile. Register here to get an alert as soon we're done.
In the meantime, if you are interested in participating in placements on this stock click "Follow" on the toolbar above.
Highlights Australian market steadies amid global shifts. Emerging undervalued companies...
Read ArticleThis article is part of the daily news updates from FNArena.com. Stay informed with the latest finan...
Read ArticleHighlights Australian tech sector shows resilience across biotechnology and software Key...
Read ArticleBiotechnology stocks can be high-risk but also high-reward. The key is latching on to one with a pro...
Read ArticleThe S&P ASX 200 Health Care index fell 13.21% in August as a tough reporting season weighed on...
Read ArticleHighlights Banks including (ASX:ANZ), (ASX:NAB) and (ASX:WBC) remained firm within the asx...
Read ArticleHighlights Recent trading activity reflects increased appetite for high-risk equity positio...
Read ArticleHighlights Spotlight on selected small-cap movements from the ASX board Sectoral shift...
Read ArticleAudeara and Ear Science Institute Australia will strive to develop a more affordable bone-conducti...
Read ArticleThe S&P ASX 200 Health Care index rose 9.05% in July with rotation into the sector gaining mome...
Read ArticleHighlights: ASX 200 trims early losses as sectors rebound Viva Energy under pressure afte...
Read ArticleHighlights Fortescue delivers strong Q4 shipment results Healthcare stocks shine despite...
Read ArticleASX falls 0.31pc with 10 of 11 sectors down Healthcare moves against the grain, up 1.04pc Fortescue...
Read ArticleOn Friday the 13th of December last year, Percheron Therapeutics (ASX:PER) CEO Dr James Garner awai...
Read ArticleThe ASX 200 Health Care Index fell 1.05% in June and remains the worst performing sector YTD down 6...
Read ArticleUBS reckons healthcare will fare better than any other ASX sector Bell Potter says Monash IVF has f...
Read ArticleThe S&P/ASX 200 Health Care Index rose 1.59% in May but remains worst performing sector YTD dow...
Read ArticleHaving produced more positive diagnostics results, Proteomics plans to launch its Promarker Endo d...
Read ArticleHighlights Life360 (360), Codan Limited (CDA) and Immutep Limited (IMM) report robust revenue...
Read ArticleASX posts 0.22pc gains, recovering from dip earlier in the day Xero brings big profit and revenue g...
Read ArticleLate-stage biotechnology specialist Immutep (ASX: IMM) has achieved significant improvement in respo...
Read ArticleAmplia says it has reached the requisite level of ‘partial responders’ in its mid-stage pancreatic...
Read ArticleImmutep Ltd (ASX: IMM) shares are catching the eye on Thursday. In morning trade, the ASX 300 stock...
Read ArticleHighlights ERW reports high-grade silver surface samples using XRF analysis IMM involved...
Read ArticleThe ASX200 is set to open nearly three quarters of a percent lower today (-0.41%), echoing a mixed p...
Read ArticleHighlights ASX 200 saw mixed sector performance with Energy and Real Estate leading gains....
Read ArticleHighlights Gold miners led gains as the ASX All Ords Gold index advanced, lifting the broader...
Read ArticleThe ASX200 closed slightly down 0.08% at 8,151 points. Energy and Real Estate were the best perfo...
Read ArticleASX Gold Index leads gains, up more than 4pc Energy sector in the green despite 2pc oil price fall...
Read ArticleImmutep (ASX: IMM) has announced a solid median overall survival (OS) rate in Cohort B of its TACTI-...
Read ArticleThe US health sector shows signs of stabilising as chaos subsides Immutep will meet with the FDA fo...
Read ArticleThe All Ordinaries Index (ASX: XAO) is down 0.3% today, but don't blame this surging ASX All Ords s...
Read ArticleHighlights S&P/ASX 200 and All Ordinaries lift following Wall Street momentum New Wor...
Read ArticleThe ASX200 is set to open nearly a third of a percent higher today (0.27%) echoing Wall Street’s pos...
Read ArticleThe S&P/ASX 200 Health Care Index rose 2.16% in April with the S&P/ASX 200 rallying 3.6% Mo...
Read ArticleImmutep Ltd (ASX:IMM) has dosed the first patient of its Phase 3 TACTI-004 non-small cell lung cance...
Read ArticleThe S&P/ASX 200 Health Care Index fell 7.66% in February with the S&P/ASX 200 down 3.79% Mo...
Read ArticlePercheron has detailed why its Duchenne muscular dystrophy trial flopped – and why it needs to fi...
Read ArticleThe S&P/ASX 200 Health Care Index fell 1.85% in December but rose 7.51% overall in 2024 Mesobl...
Read ArticleImmutep, Percheron and PYC feature in clinical trial updates Control Bionics guides to higher reven...
Read ArticleImmutep Ltd (ASX:IMM) has reported a small-scale conceptual safety test among 49 patients using flag...
Read ArticleFrom artificial intelligence (A.I) to zygotes, the biotech sector this year delivered the A to Z of...
Read ArticleThis article is part of the daily news updates from FNArena.com. Stay informed with the latest finan...
Read ArticleHere are 10 stocks rated ‘Strong Buy’ by brokers Mining, biotech and energy stocks top list Life360...
Read ArticleS&P/ASX 300 Index (ASX: XKO) healthcare stock Immutep Ltd (ASX: IMM) is charging higher today....
Read ArticleImmutep (ASX:IMM) has announced promising new data from its Phase IIb TACTI-003 trial, presented at...
Read ArticleImmutep (ASX:IMM) has announced the initiation of its TACTI-004 Phase III clinical trial, which aims...
Read ArticleASX All Ords stock Immutep Ltd (ASX: IMM) has underperformed the All Ordinaries Index (ASX: XAO) thi...
Read ArticleThe ASX 200 is expected to dip into the red this Friday, with futures down 0.27% as the booming 2024...
Read ArticleThe S&P/ASX 200 Health Care Index rose 2.89% in November as momentum returned to the sector Hea...
Read ArticleImmutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt reflects on a year marked by promi...
Read ArticleImmutep Ltd (ASX: IMM) shares ended the week on a disappointing note. The small cap ASX biotechnolog...
Read ArticleASX up, Xero leads gains Miners hit as iron ore drops, Variscan jumps 50pc Asian stocks down, Bitco...
Read ArticleImmutep (ASX: IMM) has presented new data from a Phase II investigator-initiated trial of eftilagimo...
Read ArticleThree ASX healthcare shares are making their shareholders very happy today, posting gains of 5%, 12%...
Read ArticleThis article is part of the daily news updates from FNArena.com. Stay informed with the latest finan...
Read ArticleASX healthcare stocks underperform but optimism grows Uscom, Respiri and Hitiq report mixed results...
Read ArticleImmutep (ASX:IMM) has released its annual report, detailing significant progress over the past year...
Read ArticleTo register for Friday's webinar click here. Immutep Limited (ASX:IMM) has fully recruited partici...
Read ArticleWith the gold price trading around record highs, a number of ASX 200 gold shares have been rallying...
Read ArticleHealthcare stocks are doing relatively well globally in 2024 The sector could see more recovery as...
Read ArticleCettire Ltd (ASX: CTT) shares are catching the eye with a very strong gain on Tuesday. At the time o...
Read ArticleBiotech company Immutep Ltd (ASX:IMM) has received a R&D Tax Incentive of around A$3.6 million f...
Read ArticleThe ASX200 is expected to open 0.12% lower today, despite strong gains on Wall Street. Investors in...
Read ArticleThe ASX200 is set to open 0.12% lower today, despite strong performances on Wall Street, as Australi...
Read ArticleImmutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt discusses the company's latest res...
Read ArticleIn afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record another gain. At th...
Read ArticleGood afternoon. The ASX200 has been up 0.42% at 8,134 points. The local bourse is very close to brea...
Read Article‘Wheezo’ maker Respiri says a new US deal will help to propel the company to cash-flow break even b...
Read ArticleImmutep (ASX:IMM) has reported that eftilagimod alpha (efti) combined with MSD's KEYTRUDA® shows h...
Read ArticleASX nears record high as Fed rate cut speculation grows Wall Street rallies ahead of Fed decision;...
Read ArticleCopper stocks elevated to the S&P/ASX 200 and S&P/ASX 300 including Sandfire Resources and...
Read ArticleDimerix chief Dr Nina Webster describes the three stages of drug development and the hurdles involv...
Read ArticleASX health stocks down in August and trail the broader market in 2024 CSL up 6,000pc since listing;...
Read ArticleInoviq’s NEURO-NET validated for Parkinson’s disease Nyrada’s NYR-BI03 shows safety in rats; Phase...
Read ArticleImmutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt discusses progress with the compan...
Read ArticleTo register for Friday's webinar click here. Immutep (ASX:IMM) has initiated a Phase I clinical tr...
Read ArticleIn a potential game-changer for millions of people worldwide, Immutep (ASX:IMM; NASDAQ:IMMP) has ini...
Read ArticleASX set to open higher, driven by easing inflation data in the US US PPI fell short of expectations...
Read ArticleImmutep (ASX:IMM) has confirmed it’s dosed the first human patient with its LAG-3 based autoimmune d...
Read ArticleS&P/ASX 200 Health Care index up 5pc in July, 9.5pc YTD Health sector gains momentum with expec...
Read ArticleThe EMA has rejected the Alzheimer’s drug Leqembi, developed by Eisai and Biogen There is one ASX-l...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) endured a tough sta...
Read ArticleWhile the S&P/ASX 200 Index (ASX: XJO) faces a downturn, slipping 0.9% to 7,902.4 points, severa...
Read ArticleASX healthcare stock Immutep Ltd (ASX: IMM) is surging after the company released a market-sensitive...
Read ArticleImmutep receives FDA feedback for its TACTI-004 Phase III trial design for tackling non small-cell...
Read ArticleTwo S&P/ASX 200 Index (ASX: XJO) shares are managing to swim against the retreating tide today....
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) is having a tough time on Monday. In afternoon trade, the bench...
Read ArticleImmutep (ASX:IMM; NASDAQ:IMMP), a leading biotechnology firm specialising in LAG-3 immunotherapy, ha...
Read ArticleMost investors probably wouldn't relish the idea of buying an ASX share that has already fallen by 7...
Read ArticleThe ASX is set to fall when it opens Monday, following Wall Street’s losses Major tech stocks like...
Read ArticleThe ASX200 is set to fall 0.56% after another weak day of trading on US markets. On Friday, US St...
Read ArticleImmutep has received regulatory clearance from the Netherlands for its Phase I clinical trial of IM...
Read ArticleIn afternoon trade, the S&P/ASX 200 Index (ASX: XJO) has run out of steam and is on course to...
Read ArticleASX 200 adds about 60 points after intraday record Nine of 11 sectors higher, IT weighed by US meg...
Read ArticleASX AI stocks have caught a strong bid in 2024. The artificial intelligence domain has seen tremendo...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) is having another strong session and is on course to end the...
Read ArticleTo register for today's webinar click here. Immutep (ASX:IMM) has announced positive results from...
Read ArticleGood morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highligh...
Read ArticleImmutep Limited (ASX:IMM) Executive Director and CEO Marc Voigt, Chief Medical Officer Dr Florian...
Read ArticleImmutep Ltd (ASX: IMM) shares are ending the week with a bang. In morning trade, the ASX healthcare...
Read ArticleBiotechnology company Immutep Ltd (ASX:IMM) which is developing novel LAG-3 immunotherapies for canc...
Read ArticleLendlease Group (ASX: LLC) shares are running in the opposite direction to the rest of the market to...
Read ArticleThis article is part of the daily news updates from FNArena.com. Stay informed with the latest finan...
Read ArticleNormally, the phrases '40% return' and 'bank shares' aren't uttered in the same sentence. ASX bank s...
Read ArticleThe ASX Health Care index saw a 4% increase in June Growth was driven by CSL and Cochlear Best biot...
Read ArticleBrainChip Holdings Ltd (ASX: BRN) shares were one of the weakest performers on the ASX in FY 2024. I...
Read ArticleIn afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record another decline. A...
Read ArticleTwo S&P/ASX 200 Index (ASX: XJO) stocks just scored substantial broker upgrades. One of the com...
Read ArticleThe start of the new financial year hasn't brought much joy for the Pilbara Minerals Ltd (ASX: PLS)...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) is having a subdued start to the week. In afternoon trade, th...
Read ArticleIf you've been following me on social media, you'll have noticed my feed take on a decidedly differe...
Read ArticleS&P/ASX 200 Index (ASX: XJO) coal shares are smoking hot today. How hot? Well, at the time of w...
Read ArticleLendlease Group (ASX: LLC) shares are starting the week positively. In morning trade, the ASX 200 sh...
Read ArticleAlthough the returns on offer with term deposits are the best they have been in years, and could yet...
Read ArticleASX health stocks rise in past five days, despite May uptick in inflation Healius downgrades guida...
Read ArticleASX All Ords healthcare stock Immutep Ltd (ASX: IMM) is down by 26% over the past two days, and one...
Read ArticleS&P/ASX 200 Index (ASX: XJO) stocks, taken together, moved higher in June. In afternoon trade o...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) is having a better session on Friday. In afternoon trade, the...
Read ArticleSometimes, people like me can make investing seem way too complicated. Hopefully not me, personally...
Read ArticleFleetPartners Group Ltd (ASX: FPR) shares are trading 3% higher in morning trade on Friday after it...
Read ArticleFortunately for income investors, the Australian share market is one of the most generous in the wor...
Read ArticleThe rate of inflation in Australia continues to be stronger than what the Reserve Bank of Australia...
Read ArticleASX200 falls fast for a second session after inflation steals the air in the room 7 of 11 ASX sect...
Read ArticleWhile the market closed in the red on a down day for the ASX, it wasn’t as bad as futures had predic...
Read ArticleWhen you first start out investing, you can invest in fledgling growth stocks and small caps. That's...
Read ArticleIn afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a disappointing dec...
Read ArticleImmutep sinks 35pc despite positive TACTI-003 Phase IIb trial results Investors may have had higher...
Read ArticleClinical-stage biotechnology company Immutep (ASX: IMM) has released top-line results from a Phase I...
Read ArticleImmutep Ltd (ASX: IMM) shares are having a day to forget on Thursday. In morning trade, the ASX heal...
Read ArticleImmutep Limited (ASX:IMM) Executive Director and CEO Marc Voigt, Chief Scientific Officer Professo...
Read ArticleASX to fall by 1pc when the market opens Amazon reaches $2 trillion market cap for the first time A...
Read ArticleBrainChip Holdings Ltd (ASX: BRN) shares have had a turbulent first half of the year. Despite showin...
Read ArticleEvery investor has a different risk appetite. Some investors play it safe and buy low risk, defensiv...
Read ArticleGoldman Sachs is one of the most highly respected investment banks out there. Its analysts scour the...
Read ArticleThe ASX200 closed up 0.4% – thanks to a very small rise in Australia’s latest Gross Domestic Product...
Read ArticleAussie shares rise in arvo trade Resources sectors weigh, Real Estate adds 2pc GDP lowest in 40 yea...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) is back on form on Wednesday and pushing higher. In afternoon...
Read ArticleThe Xero Ltd (ASX: XRO) share price is paused from trade on Wednesday morning. Why is the Xero share...
Read ArticleImmutep (ASX:IMM) has launched a fully underwritten equity raising of approximately $100 mil...
Read ArticleS&P/ASX 200 Health Care closed flat in May 2024 brings challenges, but hopes are high for biot...
Read ArticleASX starts June positively, extending May gains Property prices in Australia rose by 0.8% in May,...
Read Article03 Jun 2024 - A snapshot of the stocks on the move, featuring Immutep (ASX:IMM), INOVIQ (ASX:IIQ) an...
Read ArticleImmutep has launched a capital raise aiming to boost its war chest by $100 million to progress late-...
Read ArticleResearch shows Alzheimer’s is entirely preventable A poor diet and bad gut bacteria can increase th...
Read ArticleThe All Ordinaries Index (ASX: XAO) is up a solid 0.5% on Monday, with one ASX All Ords share doing...
Read ArticleIf you have a higher than average risk tolerance, then it could be worth checking out the ASX penny...
Read ArticleIf you're looking for some big returns to supercharge your portfolio, then read on. That's because a...
Read ArticleImmutep shares promising early results from Phase 2 trial on soft tissue sarcoma (STS) This trial i...
Read Article02 May 2024 - A snapshot of the stocks on the move, featuring Krakatoa Resources (ASX:KTA), Immutep...
Read ArticleTo register for Friday's webinar click here. Krakatoa Resources (ASX:KTA) has announced that new n...
Read ArticleImmutep (ASX:IMM) has announced initial encouraging data from EFTISARC-NEO, a Phase 2 invest...
Read ArticleASX Health sector was in correction territory in April Why is the health sector different from othe...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) is on form again on Tuesday and pushing higher. At the time o...
Read ArticlePointsbet Holdings Ltd (ASX: PBH) shares are having a very tough session on Tuesday. In morning trad...
Read ArticleA week or so ago, my young bloke's school invited parents to join the kids on a trip to the local ce...
Read ArticleThere’s been a breakthrough in acne treatment Scientists have found a way to use skin bacteria to c...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) is on course to record a small gain. In afternoon trade, the...
Read Article24 Apr 2024 - A snapshot of the stocks on the move, featuring Immutep (ASX:IMM; NASDAQ:IMMP), Wester...
Read ArticleImmutep (ASX:IMM; NASDAQ:IMMP) has announced preliminary topline results from Cohort B of the TACT...
Read ArticleASX to extend gains on Wednesday after Wall Street bounced back Tesla surged by 11pc after relea...
Read ArticleThe ASX close higher as unemployment rate came in lower than expected Miners rally, led by BHP as...
Read ArticleNimy Resources (ASX:NIM) advises that drilling at Block 3 within its Mons project in WA has return...
Read ArticleImmutep Limited (ASX:IMM) has entered into an agreement with the Centre for Human Drug Resea...
Read ArticleThe ASX200 slipped into the red – but only by 0.09 of a per cent at close – with Utilities sporting...
Read ArticleThe ASX200 is up around a quarter of a per cent – beating futures predictions by about half a per ce...
Read Article18 Apr 2024 - A snapshot of the stocks on the move, featuring Nimy Resources, New Age Exploration an...
Read ArticleImmutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt provides an update on the company'...
Read ArticleASX Health Index down -1.5% for February 76 biotechs rose, and 78 fell during the month But essenti...
Read ArticleViking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on p...
Read ArticleMarc Voigt, Executive Director & CEO, Immutep (ASX:IMM) is a clinical-stage biotechnology comp...
Read ArticleXi and Biden set to agree on restricting fentanyl Fentanyl is a synthetic opioid responsible for t...
Read ArticleAt the $240 million Perennial Better Future Trust, healthcare stocks are a critical component of our...
Read ArticleASX health stocks rise in past five days and outpace broader markets Blue chip ResMed slips as US F...
Read ArticleTo register for Friday's webinar click here. Sunstone Metals (ASX:STM) announced the initial Explo...
Read Article09 Nov 2023 - A snapshot of the stocks on the move, featuring Sunstone Metals (ASX:STM), Immutep (AS...
Read ArticleASX to rise despite a muted session on Wall Street Oil plunged another 2pc overnight, possibly sign...
Read ArticleImmutep (ASX:IMM) has announced that the open-label safety lead-in of its integrated AIPAC-0...
Read ArticleThe ASX experienced a subdued Monday session, with its benchmark index nearing 7000 points for the f...
Read ArticleThe Australian sharemarket began the week with a slight upward movement, as investors remained watch...
Read Article06 Nov 2023 - A snapshot of the stocks on the move, featuring Whispir (ASX:WSP), QX Resources (ASX:Q...
Read ArticleSoprano Design Australia Pty Ltd today announces its intention to make an off-market takeover bid...
Read ArticleThe Australian stock market has surged around midday, buoyed by the positive performance on Wall Str...
Read ArticleImmutep (ASX:IMM) announces new biomarker data from its phase II TACTI-002 trial for patients with p...
Read ArticleTo register for today's webinar click here. Findi (ASX:FND) has extended the existing State Bank o...
Read ArticleWelcome to the end of the trading week. ASX futures were up 1.23 per cent (85pts) at 8:30 am AEDT....
Read Article03 Nov 2023 - A snapshot of the stocks on the move, featuring Findi (ASX:FND), Immutep (ASX:IMM) an...
Read ArticleImmutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt discusses progress of the company'...
Read ArticleCancer is a nasty disease and the leading cause of death worldwide, accounting for nearly 10 million...
Read ArticleOn Tuesday, energy and mining stocks drove gains in the Australian sharemarket. Energy stocks benefi...
Read ArticleThe ASX200 lifted nearly 0.2 of a per cent by the end of the day’s session, with materials taking a...
Read Article24 Oct 2023 - A snapshot of the stocks on the move, featuring Immutep (ASX:IMM), Empire Energy (ASX:...
Read ArticleImmutep (ASX:IMM) has reported promising clinical data from the INSIGHT-003 trial at the ESMO Cong...
Read ArticleThe spotlight is on RBA Chief Michele Bullock's speech scheduled for 7pm AEDT at the Global Markets...
Read ArticleThe Australian stock market has given up all of the gains that it had made in 2023, with the benchma...
Read ArticleAustralian company Immutep (ASX:IMM) has announced positive data from a trial of its LAG-3 i...
Read ArticleThe ASX200 closed down .8 of a per cent to a new 100-day low. Energy took the biggest hit – losin...
Read ArticleBenchmark ASX index closes at new 12-month lows Energy and Materials the worst of 9 dipping ASX sec...
Read ArticleAustralian shares closed at their lowest level in a year on Monday, following a trend set by a weake...
Read ArticleStockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might h...
Read ArticleFutures suggested the ASX200 would drop – and it’s dropped almost a per cent, with all sectors in th...
Read ArticleChimeric Therapeutics up 50pc on Phase 1A CLTX CAR T results Immutep up 11pc on TACTI-002/KEYNOTE-7...
Read ArticleAt noon, the S&P/ASX 200 is 0.76 per cent lower at 6,848.40. This drop was in line with Wall Str...
Read Article23 Oct 2023 - A snapshot of the stocks on the move, featuring Immutep (ASX:IMM; NASDAQ:IMMP), Chimer...
Read ArticleImmutep (ASX:IMM; NASDAQ:IMMP) announced that their Efti, a soluble LAG-3 protein, in Combination...
Read ArticleImmutep (ASX:IMM) reveals its drug Efti, in combination with Keytruda, generates significant surviva...
Read ArticleThe Immutep Ltd (ASX: IMM) share price is jumping on Monday. In morning trade, the ASX All Ords bio...
Read ArticleAussie shares to slump once again after heavy selloff on Wall Street Traders are wary of developmen...
Read ArticleWelcome to the start of the week. ASX futures were down 65 points (0.95 per cent) heading into 8:30...
Read ArticleNews relating to Novo Nordisk’s Ozempic has led to a selloff in some ASX stocks CSL, FPH, and RMD f...
Read ArticleGlobal Health announces deal with Fujitsu Australia Althea raises $5.32m in sale and leaseback deal...
Read ArticleL’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supr...
Read ArticleConsumers are becoming more cautious due to rising living costs, but UBS analysts believe this doesn...
Read ArticleThe ASX experienced continued declines at midday, with banking stocks being particularly affected. T...
Read Article21 Sep 2023 - A snapshot of the stocks on the move, featuring Immutep (ASX:IMM), Vulcan Energy Resou...
Read ArticleImmutep (ASX:IMM; NASDAQ:IMMP) announces the regulatory authorisation of “efti”, which is the Comp...
Read ArticleASX to open lower again on Thursday The US Fed held rates steady, but opened the door for one more...
Read ArticleImmutep (ASX:IMM) has announced the regulatory authorisation of eftilagimod alpha manufactur...
Read ArticleFutures are predicting the market will open slightly lower this morning, despite yesterday’s decisio...
Read ArticleThe FDA has just approved an emergency use authorisation for new Covid-19 vaccines What is emergenc...
Read ArticleWelcome to the FNArena Corporate Results Monitor. Today's Reports: ((AMX)) - Aerometrex ((ART)) -...
Read ArticleEarnings reports dominated headlines in August Despite solid results from ASX healthcare giants, th...
Read ArticleAustralian biotech has attracted US investments in the last five years Among ASX stocks to get fund...
Read ArticleBiotech could be a US$4 trillion industry in 10 years Genetic engineering and weight loss are two g...
Read ArticleASX health stocks fall 2.4% in the past five days in line with broader markets Mesoblast crashes mo...
Read ArticleThe end of pandemic and higher rates have subdued biotech market But there are signs now the sector...
Read ArticleAustralian clinical-stage biotechnology company Immutep (ASX:IMM) says it has received posit...
Read Article31 Jul 2023 - Immunotherapy company Immutep has released its Quarterly Activities report, which high...
Read ArticleImmutep Limited (ASX:IMM; NASDAQ:IMMP), a biotechnology firm specialising in novel LAG-3 related imm...
Read ArticleAustralian retail sales experienced a 0.8% decline last month, as reported by the Australian Bureau...
Read ArticleFirst Patient Dosed in Chemotherapy-Free Triple Combination Phase II Trial Targeting Soft Tissue S...
Read ArticleThe ASX looks set to stoop lower for the last session of the week. Investors are warned to keep a...
Read Article28 Jul 2023 - A snapshot of the stocks on the move, featuring Immutep (ASX:IMM), Pointerra (ASX:3DP)...
Read ArticleASX healthcare shares are currently underperforming ASX 200 shares, but over the longer term, they’...
Read ArticleThe All Ordinaries Index (ASX: XAO) is up a healthy 4% in 2023, while ASX All Ords share Immutep L...
Read ArticleThe Bubs Australia Ltd (ASX: BUB) share price is ending the week deep in the red. In morning trade,...
Read ArticleASX 200 benchmark climbs 0.65% despite a sour lead-in from Wall Street and Europe. Real Estate sect...
Read ArticleMarc Voigt – Executive Director & CEO – Immutep (ASX:IMM) is a clinical-stage biotechnology c...
Read ArticleBrisbane-based biotech Vaxxas is working on needles-free vaccine The Nanopatch is said to be a “gam...
Read Article20 Jun 2023 - Immutep Limited (ASX:IMM), a clinical-stage biotechnology company focusing on LAG-3 im...
Read ArticleThe ASX 200 climbed 0.86% today, after the RBA said it wants you all to get fired. Energy stocks cl...
Read ArticleA couple of ASX lithium shares have been catching the eye on Tuesday with some strong gains. Letâ...
Read ArticleAustco Healthcare wins St Paul’s Hospital in Canada worth $7.4m Next Science announced a new CEO AV...
Read ArticleIn afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record another gain. The...
Read ArticleI believe that the two ASX shares Iâm going to write about in this article have the potential to...
Read ArticleThe infectious diseases space is one area that could be interesting for ethical investors An ASX co...
Read ArticleSmall cap health stocks are not known to pay dividends But there’s a handful of such stocks on the...
Read ArticleASX All Ords retail share Universal Store Holdings Ltd (ASX: UNI) crashed by almost 25% in just two...
Read ArticleAll stocks, no matter how well they perform in the long run, will have short-term dips. That’s why...
Read ArticleThe Adairs Ltd (ASX: ADH) share price suffered a big sell-off last week â it fell around 15% on F...
Read ArticleIf you have room for some new portfolio additions in June, then it could be worth considering the t...
Read ArticleSeveral new health-focused funds joined the biotech’s register including Platinum.
Read ArticleIf youâre searching for a passive income boost, then you may want to check out the ASX dividend s...
Read ArticleASX retail shares are falling amid news today of a 5.75% hike to the minimum wage and concern among...
Read ArticleIn afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on track to end the week on a positive...
Read ArticleThe Bubs Australia Ltd (ASX: BUB) share price is falling on more disappointing sales data from Chin...
Read ArticleBiotech is making a comeback in 2023 There’s been a couple of breakthroughs on the ASX this year We...
Read ArticleThe ASX 200 fell 1.37%, and the bad news kept piling up all day Inflation data knee-capped the mark...
Read ArticleThe immunotherapy biotech had brokers Bell Potter, Jefferies and Wilsons in its corner on Wednesday.
Read ArticleThe S&P/ASX 300 (ASX: XKO) has climbed 0.78% in the last two days, but this ASX 300 lithium sha...
Read ArticleImmutep (ASX:IMM) has announced it has entered into an agreement under which Charles River w...
Read ArticleASX lithium share Leo Lithium Ltd (ASX: LLL) is soaring higher today, up 13.8% in early trade. Shar...
Read ArticleShareCafeThe Week that Was: May 22-26, 2023 We at ShareCafe understand you are busy and may not have...
Read ArticleIt has been another busy week for Australiaâs top brokers. This has led to the release of a large...
Read ArticleASX health stocks have fallen in the past five days in line with broader markets Volpara Health Tec...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) tumbled on Thursday, falling 1.05% to close at 7,138.2 points....
Read ArticleThe market is continuing its downward trend for today, with the ASX200 around 0.8 per cent lower in...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) has followed Wall Streetâs lead and dropped into the red....
Read ArticleThis content is created by Smallcaps Authors. [Author : Imelda Cotton] Biotechnology company Immut...
Read ArticleImmutep (IMM) enrols and doses its first patient at its European clinical site for its integrated Ph...
Read ArticleThe Webjet Limited (ASX: WEB) share price has been on form this week. So much so, the online travel...
Read ArticleThe ASX is expected to fall today on the back of overnight losses across other global markets, namel...
Read ArticleASX lithium share Delta Lithium Ltd (ASX: DLI) may not be a household name, but it appears it is at...
Read ArticleThe average Australian’s superannuation balance leaves much to be desired for one seeking a comfort...
Read ArticleOn Wednesday, the S&P/ASX 200 Index (ASX: XJO) was out of form and dropped into the red. The...
Read ArticlePfizer said its diabetes drug works as well as Ozempic for weight loss What are the side effects of...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) struggled in Wednesdayâs session, falling 0.63% to close at...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) has dropped into the red on Wednesday. In afternoon trade, th...
Read ArticlePatry receives positive toxicology reports on PAT-DX1 Immutep says triple combination trial of Efti...
Read ArticleShareCafeUBS and Credit Suisse nearing completion of merger: ASX 0.46% lower at noon by Peter Milios...
Read Article24 May 2023 - A snapshot of the stocks on the move featuring Leo Lithium (ASX:LLL), Empire Energy (A...
Read ArticleShareCafeStocks of the Hour: LLL, EEG, IMM, CXU Leo Lithium (ASX:LLL) has a...
Read ArticleShareCafeImmutep’s Positive FDA Talks and Strong Survival Data Immutep Limited (ASX:IMM) Executive...
Read ArticleASX health stocks rise in the past five days in line with broader markets Immutep surges 46% after...
Read ArticleImmutep gets US FDA clearance to start Phase 1 study Noxopharm says its Sofra platform is effective...
Read ArticleShareCafeASX closes 0.52% higher as high iron ore price boosts bellwethers by Peter Milios At the...
Read ArticleS&P/ASX 200 closes up 0.40%, while the emerging companies index rises 0.43% Algerian mining reg...
Read ArticleThe S&P/ASX 200 Health Care (ASX: XHJ) index has slid 0.55% in the last two days, but this ASX...
Read ArticleShareCafeASX up 0.59% after surprise jobs data by Peter Milios According to the Australian Bureau...
Read ArticleShareCafeStocks of the Hour: LRS, EMH, G88, IMM Latin Resources (ASX:LRS) a...
Read Article18 May 2023 - A snapshot of the stocks on the move featuring Latin Resources (ASX:LRS), European Met...
Read ArticleStockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) pe...
Read ArticleImmutep (ASX:IMM) has reported positive results from a clinical trial of its LAG-3 immunothe...
Read ArticleRhythm Biosciences surged 70pc this morning after being granted the UK CA Mark for ColoSTAT Anteris...
Read ArticleShareCafeASX closes 0.45% lower as healthcare, tech and consumer staples suffer by Peter Milios On...
Read ArticleShareCafeRBA indicates more hikes may be necessary: ASX 0.15% lower at noon by Peter Milios The Re...
Read Article16 May 2023 - A snapshot of the stocks on the move featuring Spenda (ASX:SPX), Cettire (ASX:CTT) and...
Read ArticleImmutep (IMM) gains the green light from the US FDA to move ahead with its late-stage clinical plans...
Read ArticleShareCafeStocks of the Hour: SPX, CTT, IMM Building upon a 20-year commerci...
Read ArticleThe ASX is set to open modestly higher on Tuesday China is set to benefit from a possible US defaul...
Read ArticleThe Federal Budget delivers billions of dollars funding into healthcare and aged care Mental health...
Read ArticleImmutep (ASX IMM) has received regulatory approval from the Paul-Ehrlich-Institut, German Fe...
Read ArticleThe ASX is expected to open higher on a new week after gains continued across New York on Friday nig...
Read ArticleThe ASX is poised to open higher on Monday, tracking Wall Street’s moves ExxonMobil reports record...
Read ArticleArtificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discove...
Read ArticleThe ASX is on Thursday expected to follow the US Dow Jones index, which declined overnight following...
Read ArticleImmutep (ASX:IMM) has announced the initiation of the AIPAC-003 Phase 2/3 clinical trial of...
Read ArticleShareCafeLake Resources leads the way as ASX closes 0.27% higher by Peter Milios At the closing be...
Read ArticleShareCafeTech leaders gain as ASX rises 0.3% at noon by Peter Milios At noon, the S&P/ASX 200...
Read ArticleShareCafeStocks of the Hour: SYA, ALA, LKE, IMM On Friday, Sayona Mining (A...
Read Article17 Apr 2023 - A snapshot of the stocks on the move featuring Sayona Mining (ASX:SYA), Arovella Thera...
Read ArticleThe ASX is expected to rise on a fresh week, with eyes on US earnings as companies prepare to report...
Read ArticleDr Boreham’s Crucible: Radiopharm Theronostics By Tim Boreham ASX code: ((RAD)); NASDAQ code (propos...
Read ArticleImmutep (ASX:IMM), a clinical-stage biotechnology company developing novel LAG-3 immunothera...
Read ArticleShareCafeGains from materials and healthcare boost ASX 0.71% at noon by Peter Milios At noon, the...
Read Article31 Mar 2023 - A snapshot of the stocks on the move featuring NOVONIX (ASX:NVX), Immutep Limited (ASX...
Read ArticleShareCafeStocks of the Hour: NVX, IMM, SYA NOVONIX (NASDAQ:NVX, ASX:NVX) an...
Read ArticleShareCafeASX falls 1.4% to three-month low by Peter Milios At the closing bell, the S&P/ASX 20...
Read ArticleShareCafeASX down 1.91% at noon to lowest point since Jan by Peter Milios Earlier today, the S&...
Read Article14 Mar 2023 - A snapshot of the stocks on the move featuring Patrys (ASX:PAB), Mt Monger Resources (...
Read ArticleShareCafeStocks of the Hour: PAB, MTM, IMM Patrys (ASX:PAB) has announced t...
Read ArticleImmutep (ASX:IMM) has announced the initiation of the AIPAC-003 clinical trial evaluating it...
Read ArticleShareCafeThe Week that Was: February 27-March 3, 2023 We at ShareCafe understand you are busy and ma...
Read ArticleShareCafeImmutep (ASX: IMM) Delivering Strong Lung Cancer Data Immutep Limited (ASX:IMM) Executive...
Read ArticleShareCafeImmutep (ASX: IMM) – Webinar Presentation Marc Voigt – Executive Director & CEO – Immu...
Read ArticleShareCafeWebinar Recap – Shaw and Partners, IMM, RAD, PET & IMD Catch up on the full webinar Sh...
Read ArticleAustralian clinical-stage biotechnology company Immutep (ASX:IMM) has announced that the inv...
Read ArticleShareCafeProperty sector leads ASX 0.3% lower by Peter Milios Large property players Goodman Group...
Read ArticleShareCafeASX 0.1% lower at noon after all US indices fell over the weekend by Peter Milios At noon...
Read ArticleThe FDA declined regulate CBD-based supplements and food, citing safety reasons CBD products have g...
Read ArticleShareCafeIron ore surge not enough to lift the ASX: Aus shares close 0.16% lower by Peter Milios I...
Read ArticleShareCafeASX down 0.15% at noon despite spike in US markets by Peter Milios The global race for li...
Read ArticleJapanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based devic...
Read ArticleThe ASX will open higher this morning, defying a slump in New York Tesla shares plunged 12% Oil pri...
Read ArticleImmutep (IMM) completes 50 per cent of patient enrolment for its TACTI-003 phase IIb trial The tr...
Read ArticleLittle joy for investors in December with traditional Christmas rally not eventuating in 2022 Meteo...
Read ArticleThe long and short of 2022 is that it was a frustrating period for the Australian biotech sector but...
Read ArticleWeekly broker wrap: insurers more resilient, healthcare picks, contractors remain labour-reliant, cl...
Read ArticleShareCafeLithium slammed by GS, NSW close to energy deal with Federal Government: ASX closes 0.6% lo...
Read ArticleShareCafeLithium stocks under pressure following Goldman’s comments: ASX down 0.47% at noon by Laure...
Read ArticleImmutep (IMM) achieves commercial scale manufacturing of its lead product candidate, eftilagimod alp...
Read ArticleImagion presents positive data at world leading symposium Osteopore expands in Southeast Asia Micro...
Read ArticleShareCafeShares dip following rate hike: ASX closes 0.5% lower by Peter Milios The ASX has closed...
Read ArticleShareCafeLocal market awaits RBA rate decision: ASX falls 0.17% at noon by Lauren Hayes The Austra...
Read ArticleWell, it’s rates day here in Oz, and property owners are donning their brownest pants for a likely r...
Read ArticleShareCafeThe Week that Was: November 28-December 2, 2022 We at ShareCafe understand you are busy and...
Read ArticleASX Health sector is continuing its upward trend, marginally up this week 0.87% Sonic Healthcare a...
Read ArticleShareCafeIron ore climbs to highest price since September: ASX closes 0.3% higher by Peter Milios ...
Read ArticleImmutep (IMM) signs another collaboration agreement with Merck KGaA, Darmstadt, Germany and Pfizer f...
Read ArticleShareCafeChinese protests over lockdowns continue: Aus shares 0.07% lower at noon by Peter Milios ...
Read ArticleSonic has taken a stake in Microba Immutep enters into second deal with Merck (Germany) and Pfizer ...
Read ArticleImmutep (ASX:IMM) has announced a new clinical trial collaboration under which the Australia...
Read ArticleThe ASX is set to open slightly higher on Tuesday Wall Street fell almost 2% overnight as protests...
Read ArticleShareCafeImmutep (ASX: IMM) – A Transformative Year for LAG-3 Therapies Immutep Limited (ASX:IMM) C...
Read ArticleASX health stocks have been out of favour this year with rotation away from growth to value sector...
Read ArticleShareCafeEarly gains quickly wiped off: ASX closes the day 0.16% lower by Peter Milios All sectors...
Read ArticleThe ASX gave up early gains as last week’s fierce global share rally showed signs of losing momentum...
Read ArticleShareCafeMarket losing momentum, materials the saviour: ASX flat at noon by Lauren Hayes Last week...
Read ArticleThe share market touched a five-month high before shedding its gains as a decline in US futures unde...
Read ArticleImmutep (IMM) receives a $986,000 tax refund from the Australian government’s research and developme...
Read ArticleHighlights Australian shares opened higher on Monday. The ASX 200 gained in the opening t...
Read ArticleImugene (IMU) presents new data for its onCARlytics oncolytic virus at the Annual Meeting of the Soc...
Read ArticleImmutep (IMM) receives two new patents from the Japanese Patent Office and South Korean Patent Offic...
Read ArticleShareCafeA sea of red in today’s trading: ASX closes 1.84% lower by Peter Milios All but one secto...
Read ArticleShareCafeAll red across the board following US rate hike sentiment: ASX down 1.96% at noon By Lauren...
Read ArticleThe All Ordinaries Index (ASX: XAO) may be sinking today but that hasnât stopped a couple of ASX...
Read ArticleHitIQ signs deal with Western Australian Football Commission Rhthym Bio expands into NZ Immutep’s P...
Read ArticleThe ASX is set to plunge on Thursday after a crash in New York US Fed unleashed another jumbo 75bp...
Read ArticleShareCafeASX increases slightly ahead of today’s rate rise: Aus shares 0.3% higher at noon by Peter...
Read ArticleImmutep (IMM) is given approval by the Independent Data Monitoring Committee (IDMC) to carry on with...
Read ArticleShareCafeMarket unfazed by CPI data: ASX finishes 0.18% higher by Peter Milios CPI data from the S...
Read ArticleShareCafeAustralian headline inflation hits highest in 32 years: ASX up 0.12% at noon by Lauren Haye...
Read ArticleNeurotech says its NTI164 drug for paediatric autism showed improvements in symptoms Arovella closi...
Read ArticleShareCafeEnergy and Materials only sectors left lagging: ASX closes 0.28% higher by Peter Milios I...
Read ArticleShareCafeOptimism out of the US boosts sentiment: ASX up 0.6% at noon by Lauren Hayes Positive gai...
Read ArticleWe take a look at how the 15 biotech IPOs that listed in 2021 are faring now Only two IPO stocks fr...
Read ArticleShareCafeImmutep (ASX: IMM) Receives Fast Track Designation from FDA Immutep Limited (ASX: IMM) C...
Read ArticleEmerging gold miner Tietto Minerals has a new Chinese Mining giant as a substantial shareholder Env...
Read ArticleDuring latest period of volatility many health stocks have seen their share prices remain quite sta...
Read ArticleShareCafeEnergy’s advancements just enough to lift the ASX: Aus shares close 2.2% higher by Peter Mi...
Read ArticleAustralian immunotherapy company Immutep has secured fast-track designation from the US FDA...
Read ArticleBlood clot programs have taken the spotlight recently as new discoveries made Two ASX health stocks...
Read ArticleImmutep (IMM) receives US FDA Fast Track designation for its efti drug candidate as a treatment for...
Read ArticleParadigm successfully meets primary endpoint of Phase 2 trial Immutep granted Fast Track designatio...
Read ArticleThe Imugene Limited (ASX: IMU) share price had a rough month despite multiple clinical trial update...
Read ArticleImmutep (IMM) receives a $2.7 million research and development tax incentive from the French Governm...
Read ArticleImmutep has provided a clinical development update for its first-in-class LAG-3 antigen-pres...
Read ArticleImmutep (IMM) signs a material transfer agreement with the Maria Skłodowska-Curie National Research...
Read ArticleUscom’s device is included in China’s emergency guidelines Poland provides grant for Immutep’s Phas...
Read ArticleShareCafeEvening Report: 30 August, 2022 by Paul Sanger Australian shares have clawed back some of...
Read ArticleImmutep (IMM) receives a new patent for its immunotherapy treatment for cancer from the Japanese Pa...
Read ArticleShareCafeLunch Report: 30 August, 2022 by Paul Sanger The ASX had a solid start to the trading ses...
Read ArticleShareCafeStocks of the Hour: 30 August, 2022 Cobre (ASX:CBE) continues to k...
Read Article30 Aug 2022 - A snapshot of the stocks on the move featuring Cobre (ASX:CBE), Immutep (ASX:IMM) and...
Read ArticleIt is the last day of the busiest week in the August earnings season. Thankfully, you can ease into...
Read ArticleImmutep (ASX:IMM) has announced new interim data from lung cancer patients in one of its key...
Read ArticleImmutep Ltd (ASX: IMM) shares underperformed in FY22 as markets took a turn for the worse. Most of...
Read ArticleUS FDA approves the first clinical trial using naturally derived psychedelic drugs It could open po...
Read ArticleASX biotech shares incurred heavy losses in FY22 as investors piled out of risk assets and moved in...
Read ArticleThe Immutep Ltd (ASX: IMM) share price plunged lower in June despite the company announcing seeming...
Read ArticleASX healthcare shares were a mixed basket this past financial year. After a healthy first half of...
Read ArticleA recent research reveals which biotech segments VCs are ploughing billions of dollars into We list...
Read ArticleShareCafeEvening Report: 6 July, 2022 by Lauren Evans Australian shares spent the afternoon in the...
Read ArticleResApp gets clearance from the US FDA Immutep is granted patent in Japan Paradigm Biopharma to comm...
Read ArticleShareCafeLunch Report: 6 July, 2022 by Melissa Darmawan The Australian sharemarket has been choppy...
Read ArticleImmutep (IMM) is granted a Japanese patent for its pre-clinical product candidate, IMP761, valid un...
Read Article06 Jul 2022 - Immutep (ASX:IMM) has been granted a Japanese patent for its IMP761, an immunosuppress...
Read ArticleASX 200 healthcare shares were defensive in June but finished the month down overall. The benchmar...
Read ArticleShares of biotech Immutep Ltd (ASX: IMM) have had a hard time this year to date, down 35% since tra...
Read ArticleExchange-traded funds (ETFs) can be very useful for investing in shares. ETFs make it to invest pas...
Read ArticleThe Immutep Ltd (ASX: IMM) share price has gyrated in recent months, having slumped from a 52-week...
Read ArticleThis article was originally published on Fool.com. All figures quoted in US dollars unless otherwise...
Read ArticleThis article was originally published on Fool.com. All figures quoted in US dollars unless otherwise...
Read ArticleMen are more likely to invest in ASX shares than women. Thatâs according to a new YouGov survey c...
Read ArticleShareCafeImmutep (ASX:IMM) TACTI-002 data presented at ASCO 2022 Immutep Limited (ASX:IMM) Execut...
Read ArticleAn additional news report on the recommendation, valuation, forecast and opinion changes for ASX-lis...
Read ArticleIn Short & Caught, Stockhead recaps the ASX stocks that are the most shorted and have had the gr...
Read ArticleImmutep (ASX:IMM) has released new data from the phase 2 lung cancer trial evaluating its le...
Read ArticleShareCafeEvening Report: 6 June, 2022 by Lauren Evans The Aussie sharemarket remained in the red f...
Read ArticleShareCafeLunch Report: 6 June, 2022 by Melissa Darmawan The Australian sharemarket has retreated t...
Read ArticleUS FDA approves Clarity Pharma’s IND application Radiopharma-focused biotech, Clarity Pharmaceutical...
Read Article06 Jun 2022 - A snapshot of the stocks on the move featuring Immutep (ASX:IMM), Liontown Resources (...
Read ArticleImmutep (IMM) publishes new “favourable” data from its first line non-small cell lung cancer (NSCLC...
Read ArticleASX healthcare index finishes another week in the red Enterprise imaging stocks tipped to be a firs...
Read ArticleMay. Let’s start with US markets. Because May in the US started with the Dow making its biggest gain...
Read ArticleThe last 30 days have been bright for the Immutep Ltd (ASX: IMM) share price. The biotechnology com...
Read ArticleRace Oncology completed dosing stage of Phase, eyes Phase 2 trial Immutep presents trials data at A...
Read ArticleImmutep (IMM) publishes new interim data from Part A of its second-phase TACTI-002 trial showing “f...
Read ArticleASX to open 1% higher this morning Wall Street surge in a broad based rally overnight April retail...
Read ArticleShareCafeImmutep Limited (ASX:IMM) Investor Presentation Immutep Limited (ASX:IMM) Executive Direct...
Read ArticleASX Health stocks endure another topsy-turvy week ending in red Monash IVF makes two key purchases...
Read ArticleImmutep (ASX:IMM) has announced the appointment of four new members to its Clinical Advisory...
Read Article11 May 2022 - A snapshot of stocks in the healthcare sector, including Antisense Therapeutics (ASX:A...
Read ArticleHealthcare and life sciences expert Scott Power – a senior analyst with Morgans Financial for 24 yea...
Read ArticleBiotechnology ASX shares have been one of the biggest victims of persistent inflation and rising in...
Read ArticleImmutep (IMM) sees a significant increase in innate and adaptive immune response biomarkers in its...
Read ArticleImmutep’s (IMM) new interim data is selected for presentation at the the world’s largest gathering...
Read ArticleThe Healthcare sector has been struggling as the pandemic wanes But most money managers are still b...
Read ArticleShareCafeHow Immutep Treats Head & Neck Cancer While Immutep boasts development candidates th...
Read ArticleThe healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak mark...
Read ArticleBiotech sector has had a tough time recently But there are signs of things improving this year A lo...
Read ArticleBiotechnology company Immutep (IMM) announces new interim data in its treatment of second line meta...
Read ArticleThe healthcare sector is Australia’s biggest employer, employing 1 in 7 Aussies or roughly two milli...
Read ArticleASX set to rise as US tech stocks rally Sectors that got a big boost from Fed Budget include road a...
Read ArticleHighlights Biotechnology companies research living organisms to develop drugs and other products...
Read ArticleImmutep (IMM) has recorded new data from second line non-small cell lung cancer (NSCLC) patients fr...
Read ArticleASX to open 0.6% lower Commodities bounce back as EU and US to discuss embargo on Russian energy Au...
Read ArticleBiotech company Immutep (IMM) receives a patent from the Japanese Patent Office for LAG525 The pate...
Read ArticleASX biotech shares have, as a whole, had a remarkably poor run over the last 6 months. Here’s what...
Read ArticleImmutep (IMM) receives “constructive feedback” from the US Food and Drug Administration (FDA) regar...
Read ArticleASX to rise as global equities rebound Wall Street and European stocks rebounded strongly overnight...
Read ArticleTelehealth was already a growing space even before the pandemic, but COVID had launched it into the...
Read ArticleMs Turnbull rejoins Immutep’s board having previously served as its chair from October 2010...
Read ArticleShareCafeBuying Opportunities Beckon Amid Biotech Bloodbath The sharp retreat in global biotech valu...
Read ArticleThe ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial t...
Read ArticleImmutep (IMM) is granted a new patent by the Australian Patent Office The claims of the new patent...
Read ArticleVenture capitalist Grant Chamberlain, a partner in Sydney VC OneVentures, has died after falling fro...
Read ArticleWith 2021 now officially behind us (at long last!), we asked our Foolish contributors to compile a...
Read ArticleAt the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, be...
Read ArticleASX biotech shares were a mixed bag in 2021. Several of the majors came in behind their benchmarks...
Read ArticleWith COVID-19 Omicron surging around the globe, ASX healthcare shares are back in the spotlight. Wh...
Read ArticleIt’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and...
Read ArticleThe life sciences sector has emerged into the spotlight ever since the pandemic began. In the US, th...
Read ArticleShareCafeThe Week that Was – December 13-17, 2021 We at ShareCafe understand you are busy and may no...
Read ArticleImmutep (IMM) signs a manufacturing service agreement with Northway Biotech to manufacture its prec...
Read ArticleThe ASX 200 Health Index (XHJ) has dropped by almost 5% at the time of writing, compared to the broa...
Read ArticleThe Immutep Ltd (ASX: IMM) share price is rising today after news of a deal with a European company...
Read ArticleImmunotherapy development company Immutep (ASX:IMM) has signed a Manufacturing Service Agree...
Read ArticleShareCafeLatest from Immutep (ASX: IMM) on LAG-3 and 2022 Outlook Immutep (ASX: IMM) are global lea...
Read ArticleIt’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 los...
Read ArticleThe Immutep Ltd (ASX: IMM) share price is in the red this morning, down 1.05% at the time of writin...
Read ArticleImmutep (IMM) has treated the first five patients in its study evaluating eftilagimod alpha (efti)...
Read ArticleWall Street falls further on Omicron fears The US stock markets once again fell heavily overnight, a...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleTrading Places is Stockhead’s recap of the buys and sells of ASX small cap shares by fund managers a...
Read ArticleIt’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 los...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleImmutep (IMM) completes recruitment for its phase II study for non-small cell lung cancer The last...
Read ArticleThe ASX 200 Health Index (XHJ) is up by 0.80% at the time of writing, compared to the broader index...
Read ArticleTech stocks gain on Wall Street US stocks were mixed overnight, but investors’ appetite were mainly...
Read ArticleThe ASX 200 Health Index (XHJ) is up by 1.5% at the time of writing, compared to the broader index w...
Read ArticleWall Street was lower for the week US stocks rebounded on Friday, but finished the week lower after...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleDespite what Immutep’s two-day sell-off may have you thinking, now is the time the biotech giants ar...
Read ArticleIn afternoon trade, the S&P/ASX 200 Index (ASX: XJO) has followed the lead of US markets and is...
Read ArticleShares in Australian biotechnology company Immutep Ltd (ASX: IMM) are tanking on Wednesday morning,...
Read ArticleStockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) per...
Read ArticleIn October, the Chinese government released its intellectual proprietary (IP) patents strategy paper...
Read ArticleIntelicare nabs MercyCare contract for its AI sensor tech Telix scores TGA approval for prostate ca...
Read ArticleThe Immutep Ltd (ASX: IMM) share price is climbing today after the biotechnology company announced...
Read ArticleImmutep (IMM) is granted a new patent by the Chinese Patent Office for its lead product candidate,...
Read ArticleShares in Immutep (IMM) open green after the company announced positive feedback from European regu...
Read ArticleNasdaq at all time high Tech stocks rallied in New York overnight, pushing up the Nasdaq composite i...
Read ArticleShares in clinical stage biotechnology company Immutep Ltd (ASX: IMM) are inching higher in afterno...
Read ArticleMoneyTalks is Stockhead’s regular recap of the stocks, sectors and trends that fund managers and ana...
Read ArticleShareCafeThe Week that Was – October 11-16, 2021 We at ShareCafe understand you are busy and may not...
Read ArticleShareCafeImmutep Taking the Fight to Cancer In May 2021, Corporate Connect analyst Marc Sinatra publ...
Read ArticleGlobal stocks sell off as bond yields rise All three US stock market benchmark indexes fell sharply...
Read ArticleThe Immutep Ltd (ASX: IMM) share price is pushing higher again on Monday despite the market decline...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleShareCafeThe Week that Was – August 30-September 3, 2021 We at ShareCafe understand you are busy and...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleAlthough earnings results were the main theme in August, there were also some notable healthcare bre...
Read ArticleSmall-cap biotech stock Immutep [ASX:IMM] is on the up today. Shares are currently trading 7.92% hig...
Read ArticleSmall-cap biotech stock Immutep Ltd [ASX:IMM] is on the up today. The IMM share price is currently...
Read ArticleIn afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is off its intraday lows but still trading...
Read ArticleThe Immutep Ltd (ASX: IMM) share price is gaining today following news of the company’s Two ACTive...
Read ArticleShareCafeImmutep Leading the development of immunotherapy for cancer and autoimmune diseases Fund...
Read ArticleImmutep (ASX:IMM) has announced that its Chinese partner for eftilagimod alpha (efti), EOC P...
Read ArticleThe CAR T-cell therapy (Chimeric Antigen Receptor) has been billed as a radical new way to cure canc...
Read ArticleThe ASX 200 closed at 7,488 points which was 0.04% down from yesterday but up 0.37% from last Friday...
Read ArticleHighlights Emyria has entered into a Master Services Agreement with Calvert Labs, a leading Nort...
Read ArticleThe Immutep Ltd (ASX: IMM) share price has stepped into the green from the opening of trade on Frid...
Read ArticleWall Street snaps three-day gain streak All three US stock market indexes fell last night, and snapp...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 7...
Read ArticleSummary Latitude Group Holdings has cracked a deal for fintech Symple to accelerate business gr...
Read ArticleTrading Places is Stockhead’s recap of the buys and sells of ASX small cap shares by fund managers a...
Read ArticleSummary Emyria has signed a deal with the University of Western Australia (UWA) to develop a nov...
Read ArticleASX 200 health stocks index (XHJ) rose by 0.23% this morning, compared to the broader index which ro...
Read ArticleImmutep Ltd (ASX: IMM) shares are lifting on Thursday morning following an clinical trial update fr...
Read ArticleImmutep (ASX:IMM) has announced that the first patient has been enrolled and safely dosed in...
Read ArticleWall Street mixed on Fed’s statement US stock markets were mixed overnight, after the US Fed Vice Ch...
Read ArticleThe ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the...
Read ArticleShareCafeInstitutions Support Immutep Capital Raising Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Imm...
Read ArticleInvestor funds continue flowing into ASX listed biotechnology shares this year, with a total of alm...
Read ArticleImmutep (ASX:IMM) has announced that its share purchase plan has closed with the company rec...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 7...
Read ArticleHealthcare is a constantly changing industry in which you may be asking yourself if your investment...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52...
Read ArticleImmutep (ASX:IMM) and Opthea (ASX:OPT) both received the blessing of the FDA for their clinical tria...
Read ArticleShares in Immutep Ltd (ASX: IMM) are soaring today following news of its latest drug trial. Current...
Read ArticleAustralian immunotherapy company Immutep (ASX:IMM) has announced a $60 million capital raise...
Read ArticleSummary The ASX dropped over 2% to hit intraday low of 7,216.60, led by sharp sell-off in financ...
Read ArticleThe Immutep Ltd (ASX: IMM) share price has returned from its trading halt and is sinking lower on M...
Read ArticleStockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) per...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleFor the second day in a row, the Immutep Ltd (ASX: IMM) share price will be frozen at market open....
Read ArticleThe ASX plummeted into the red today despite positive jobs data out of the ABS, which showed unemplo...
Read ArticleCancer and auto-immune disease drug developer Immutep landed in front of fund managers on Thursday m...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleThere’s no two ways about it, melanoma kills, especially here in Australia. We have one of the highe...
Read ArticleShareCafeAlzheimer’s Decision Sends Positive Message to Aussie Biotechs The US Food and Drug Adminis...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has ret...
Read ArticleSummary The ASX 200 hit a fresh high of 7,315.60 on Tuesday amid broad-based buying. The index...
Read ArticleThe Immutep Ltd (ASX: IMM) share price jumped by more than 5% in morning trade to 69 cents followin...
Read ArticleImmutep (ASX:IMM), a company developing novel LAG-3 related immunotherapy treatments for can...
Read ArticleWall Street mixed as AMC gets pumped again Major indices in the US were mixed last night, ahead of T...
Read ArticleSummary The ASX 200 continued gaining momentum on Thursday, hitting a fresh record high. The ma...
Read ArticleThe Immutep Ltd (ASX: IMM) share price slipped today, despite the biotechnology company announcing...
Read ArticleLast month, the ASX finally reached its pre-pandemic high, went in circles for a couple of weeks the...
Read ArticleThe Immutep Ltd (ASX: IMM) share price is bouncing around today after the biotechnology company ann...
Read ArticleImmunotherapy company Immutep (ASX:IMM) has announced a new collaboration and supply agreeme...
Read ArticleIron ore pushes back near US$200/tonne again The US and UK stock markets were closed on Monday for t...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleImmutep (ASX:IMM), a biotechnology company developing novel immunotherapy treatments for can...
Read ArticleSummary The ASX 200 is trading lower by 8.60 points or 0.12% to 7,106.60 at the close, weighed d...
Read ArticleThe Immutep Ltd (ASX: IMM) share price finished strongly today. This came after the company announc...
Read ArticleIt was a good day for some of ASX-listed cancer therapy stocks yesterday, with three companies relea...
Read ArticleSummary The ASX 200 trades higher by 15.20 points or 0.22% to 7045.50 at the close, led by gains...
Read ArticleBiotech Global Health (ASX:GLH) topped this week’s Running Hot list, in the wake of more steady gain...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleSummary The ASX 200 is set to close the week with narrow gains, led by a strong rally in healthc...
Read ArticleSummary The ASX 200 gained 89.50 points or 1.29% to 7021.20 amid broad-based buying. Nine of th...
Read ArticleSummary The ASX 200 is heading towards its worst performance since late February, down 2% at 692...
Read ArticleSummary Island Pharmaceuticals and AdAlta have obtained patent protection for their lead program...
Read ArticleCancer immunotherapy developer Immutep Ltd [ASX:IMM] share price is trading neutral at time of writi...
Read ArticleThe ASX 200 has rebounded from yesterday’s loss though the technology sector has weighed on the mark...
Read ArticleShareCafeImmutep: A leader in a league alongside global Pharma giants Immutep (IMM.ASX) is one of th...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleThe Immutep Ltd [ASX:IMM] share price is up 11.4% today after securing fast track designation from t...
Read Article08 April 2021 - Biotechnology company Immutep (ASX:IMM) has received a fast-track approval from the...
Read ArticleImmutep (ASX:IMM) shares have hit their highest level in early trade after the Sydney biotech compan...
Read ArticleIn late morning trade the S&P/ASX 200 Index (ASX: XJO) is on form again and charging higher. At...
Read ArticleSource:Khakimullin, Shutterstock Summary The ASX 200 on Thursday opened higher, up 13.70 poin...
Read ArticleThe Immutep Ltd (ASX: IMM) share price has been a strong performer again on Thursday. In morning tr...
Read ArticleImmutep (ASX:IMM) has announced that the US FDA has granted fast-designation to its lead pro...
Read ArticleS&P 500 at record high again, after release of Fed minutes S&P 500 has set a record high aga...
Read ArticleSource:elwynn, Shutterstock Summary Nexion Group Ltd (ASX:NNG) on Thursday announced that it ha...
Read ArticleSource:Khakimullin , Shutterstock Summary Immutep Ltd (ASX:IMM) announced that its lead product...
Read ArticleSource: DG PhotoStock, Shutterstock Summary ASX-cannabis player Bod Australia has obtained a bi...
Read ArticleThe Immutep Ltd (ASX: IMM) share price is climbing in late-morning trade after announcing a new Eur...
Read ArticleImugene (ASX:IMU) shares have hit an all-time high after the Sydney biotech company announced its ca...
Read ArticleWall Street slides, as IMF raises global growth forecast All major US indices slid on Tuesday, but s...
Read ArticleAustralian company Immutep (ASX:IMM) says positive trial results from a new combination incl...
Read ArticleIn afternoon trade, the S&P/ASX 200 Index (ASX: XJO) has given back its morning gains and is tu...
Read ArticleStockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) per...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleSource:ShutterstockProfessional, Shutterstock Summary Lefroy Exploration has been making the he...
Read ArticleThe best performer on the All Ordinaries index on Friday by some distance has been the Immutep Ltd...
Read ArticleImmutep (ASX:IMM) shares have spiked after Bristol Myers Squibb announced that a drug similar to Imm...
Read ArticleStockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) per...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks f...
Read ArticleImmutep (ASX:IMM) shares closed 10.5 per cent higher on Tuesday after the Sydney biotech announced i...
Read ArticleSource: CI Photos, Shutterstock Summary ASX-listed leading immunotherapy developer Immutep Limi...
Read ArticleThe Immutep Ltd (ASX: IMM) share price is soaring in early-afternoon trade. This comes after the co...
Read ArticleImmutep (ASX:IMM), an Australian biotechnology company developing novel immunotherapy treatm...
Read ArticleImmutep Ltd (ASX: IMM) shares will be on watch this morning after the company announced it has secu...
Read ArticleThe Immutep Ltd (ASX: IMM) share price is down 1.59% at the time of writing trading at 31 cents a s...
Read ArticleSummary Respiri Limited announced that Pharmacy Catalyst members to provide support to sales of...
Read ArticleWhen it comes to biotech stocks, few are as ambitious as Immutep Ltd [ASX:IMM]. Because when they’re...
Read ArticleImmutep (ASX:IMM) shares are up nearly five per cent this morning after the Sydney biotech said a tr...
Read ArticleSummary Global biotech company Immutep announces the advancement in Phase 2 trial assessing efti...
Read ArticleA trial of biotechnology company Immutep's (ASX: IMM) experimental cancer drug on COVID-19 patients...
Read ArticleSummary Active biotechnology player Immutep has completed enrolment and dosing for the last pati...
Read ArticleThe Immutep Ltd (ASX: IMM) share price has failed to rally this morning after the company released...
Read ArticleIt has been a disappointing day for the S&P/ASX 200 Index (ASX: XJO) on Wednesday. In afternoon...
Read ArticleIn morning trade the Immutep Ltd (ASX: IMM) share price is storming higher following the release of...
Read ArticleSummary Immutep Ltd (ASX:IMM) received a US patent for its lead active immunotherapy candidate e...
Read ArticleShareCafeImmutep: fighting the good fight Immutep (ASX: IMM) are global leaders in the understanding...
Read ArticleThe Immutep Ltd (ASX: IMM) share price is on watch this morning on news the company will significan...
Read ArticleThe Immutep Ltd (ASX: IMM) share price is on fire today, rising close to 60%. Immutep shares closed...
Read ArticleImmutep Limited (ASX: IMM) announced that its Chinese partner, EOC Pharma, will begin a new Phase II...
Read ArticleSmall-cap immunotherapy company Immutep Ltd [ASX:IMM] is absolutely flying today. The IMM share pric...
Read ArticleShareCafeAustralia…One Hour In…ASX down 30 points ASX200 down 30 points (0.5%) to 6693. UK PM Bori...
Read ArticleImmunotherapy company Immutep (ASX:IMM) has announced what it describes as promising overall...
Read ArticleGlobal biotechnology company Immutep (ASX: IMM) has announced its Chinese partner EOC Pharma will co...
Read ArticleSummary Despite the challenges imposed by COVID-19, Volpara Heath delivered a substantial 38% re...
Read ArticleIn afternoon trade the S&P/ASX 200 Index (ASX: XJO) is fighting back and is off its lows. The b...
Read Article19 Nov 2020 - Immutep Limited (ASX:IMM) is advancing clinical development for its lead product candi...
Read ArticleImmutep (ASX:IMM) has announced the completion of a $29.6 million share placement to profess...
Read ArticleThe Immutep Ltd (ASX: IMM) share price went flying up this morning as the company announced encoura...
Read ArticleAn additional news report on the recommendation, valuation, forecast and opinion changes for ASX-lis...
Read ArticleImmutep (ASX:IMM) has announced a new licence and collaboration agreement with Laboratory Co...
Read ArticleSydney biotech Immutep has partnered with S&P500 stock LabCorp to develop a diagnostic test help...
Read ArticleImmutep (ASX:IMM) has signed an agreement with the University Hospital Pilsen in the Czech R...
Read ArticleSydney biotech Immutep (ASX:IMM) has agreed to let a Czech hospital test its lead drug candidate on...
Read ArticleThe Immutep Ltd (ASX: IMM) share price is heading lower today after the company announced its quart...
Read ArticleAustralian company Immutep (ASX:IMM), which is focused on the development of novel immunothe...
Read ArticleShareholders in Antisense Therapeutics, Amplia Therapeutics and Immutep all had reason to smile this...
Read ArticleSummary Biotech player Immutep Limited reported interim data from its ongoing INSIGHT-004 Phase 1...
Read ArticleFor many companies, making headway in a clinical trial is cause for celebration. But today, Immutep...
Read ArticleThree cancer patients’ lesions disappear after Immutep’s (ASX:IMM)treatment Treated with efti and Me...
Read ArticleThe Immutep Ltd (ASX: IMM) share price is today flying as the company announced a number of results...
Read ArticleBiotechnology company Immutep (ASX: IMM) has unveiled results from two parallel clinical studies int...
Read ArticleImmutep (ASX:IMM) has announced it and research partner Monash University have received a gr...
Read ArticleEstia Health (ASX:EHE), an aged care operator with two homes in Melbourne’s 10 clusters in the secto...
Read ArticleShareCafeInvestors Are Listening As Immutep Eyes Revolutionary Cancer Treatments Immutep CEO Marc Vo...
Read ArticleA quick wrap of the ASX’s key winners and losers on Wednesday, July 15. Data is taken after the mark...
Read ArticleBiotech company Immutep (ASX: IMM) has been granted a US patent directed to embodiments of LAG525, a...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleBell Financial Group (ASX:BFG) is expecting to book a higher $23.5m first-half profit, but investors...
Read ArticleAustralian immunotherapy company Immutep (ASX:IMM) has announced it has enrolled and safely...
Read ArticleCancer therapeutics biotech Immutep (ASX:IMM) has enrolled and dosed the last patient for a segment...
Read ArticleInvestors have welcomed new data from Australian biopharmaceutical company Immutep from a tr...
Read ArticleBiotechnology company Immutep (ASX: IMM) has published results from two ongoing clinical studies, ju...
Read ArticleShareCafeAustralian Ethical On Emerging Biotech Company Immutep (ASX:IMM) Immutep Ltd (ASX:IMM) i...
Read ArticleWant to know which stocks the fund managers have been putting their money in (and out) of? We’ve bee...
Read ArticlePre-revenue biotech and medtech companies are still not eligible for the Jobkeeper wage subsidy acco...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. Of the ASX’s 137-odd small ca...
Read Article29 Apr 2020 - Biotech company Immutep (ASX:IMM) has today successfully completed a $12 million place...
Read ArticleCancer hopeful Pharmaxis (ASX: PXS) is moving ahead with a treatment for a rare bone cancer called m...
Read ArticleImmunotherapy drug company Immutep is seeking a new injection of funds to finance its clinical devel...
Read ArticleImmutep (ASX:IMM), a biotechnology company developing novel immunotherapy treatments for can...
Read ArticleClinical trials are being shuttered in increasing numbers in Australia because of the risks posed by...
Read ArticleAustralian company Immutep (ASX:IMM) has announced it has worked with its partner EOC Pharma...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleStockhead’s resident Health and Biotech expert Tim Boreham is putting down the microscope and pickin...
Read ArticleThe ASX is cracking down on biotech and health companies disclosures around possible coronavirus-lin...
Read ArticleImmutep (ASX:IMM) has announced the US FDA has approved a new Investigational New Drug appli...
Read ArticleBiotechnology company Immutep (ASX: IMM) has received approval from the US Food and Drug Administrat...
Read ArticleThe cat’s not out of the bag yet, but investors are betting that when the feline does escape it will...
Read ArticleThe Sydney-based biotechnology Immutep (ASX:IMM) company has released new positive data from...
Read ArticleImmutep (ASX:IMM) has announced it will present more mature interim TACTI-002 clinical data...
Read ArticleA rebound in our big banks saw the Aussie stock market recoup half of yesterday’s heavy losses today...
Read ArticleShares in cancer treatment specialist Immutep (IMM) are trading strong today on the back of a healt...
Read ArticleThe health sector was the most successful sector on the ASX in 2019. Various small caps made several...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. Of the ASX’s 136-odd small ca...
Read ArticleBiotech company Immutep (IMM) has expanded part C of its TACTI-002 and AIPAC studies due to positiv...
Read ArticleBiotech company Immutep (ASX: IMM) intends to expand ongoing development of its lead drug candidate...
Read ArticleThe new-look ServTech is pushing its virtual reality technology into dentistry training, being paid...
Read ArticleWhether a day trader or a long-term investor, we often examine research released by industry experts...
Read ArticleShares in cancer-fighting biotech Immutep (ASX:IMM) have risen to eight-month highs today, on the ba...
Read ArticleThere are no shortage of small cap health and biotech companies listed on the ASX — around 140 or so...
Read ArticleDual Listing: When a stock gets listed on two or more stock exchanges, we say that the stock has a d...
Read ArticleSmall cap stocks are the stocks of those enterprises that have a low market capitalisation. Estimate...
Read ArticleImmutep (ASX:IMM) has announced "mature positive efficacy" data from its TACTI-mel Phase 1 c...
Read ArticleBiotech company Immutep (ASX:IMM) just got some positive results in a Phase I clinical trial for its...
Read ArticleBiotechnology company Immutep (ASX: IMM) has reported “mature positive efficacy data” from a Phase I...
Read ArticleSydney-based biotechnology company Immutep (ASX: IMM) has reported a successful rollout to Part A of...
Read ArticleShares in Bionomics (ASX:BNO) have flown to their highest point since May as it looks redo the faile...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleImmutep (ASX:IMM) has announced that the requisite number of predefined patient responses ha...
Read ArticleGSK has paid Australian immunotherapy company Immutep (ASX:IMM) a $7.4 million milestone pay...
Read ArticleSydney biotech company Immutep is receiving a $7.4 million milestone payment from GSK as it begins a...
Read ArticleCancer-fighting biotech Immutep (ASX:IMM) has risen off 10-year-long lows after flagging a payment o...
Read ArticleOn Stockhead today, the disconnect between federal and state governments on coal, private equity dea...
Read ArticleShares in Immuron took a 17 per cent hit this morning after the company revealed its IMM-124E drug d...
Read ArticleShort & Caught is Stockhead’s fortnightly recap of which ASX small cap stocks are heavily shorte...
Read ArticleIn this week’s recap of substantial holders, Australian Super became an substantial holder in Gage R...
Read ArticleThe benchmark index S&P/ASX 200 is trading at 6,665.7 on 10 July 2019 (AEST 01:58 PM), up 0.45%,...
Read ArticleA company may require more funds over and above its retained earnings in order to expand its existin...
Read ArticleASX-listed biotech Immutep has raised about $10 million in an equity deal through Bell Potter Securi...
Read ArticleAustralia is home to some of the top physicians as well as healthcare professionals. For more than 3...
Read ArticleImmutep (ASX:IMM) has completed patient enrolment of the Phase 2b Active Immunotherapy PACli...
Read ArticleThe below-mentioned health care stocks have come up with significant updates today. Let’s take a qui...
Read ArticleThe Australian Healthcare System is amongst the most inclusive in the world, and it offers a wide ra...
Read ArticleSydney-based Immutep (ASX:IMM) has announced that the first patient in the INSIGHT-004 phase...
Read Article06 Jun 2019 - Biotech company Immutep (ASX:IMM) reports that the first patient in the INSIGHT-004 Ph...
Read Article
Open an account with an online broker of your choice. If you do not have an existing broker, consider Vested Equities' A$9.50 flat fee platform.
Sign up now »Place your order however you wish. If you need advice on buying or selling, you should seek the assistance of a full service financial adviser experienced in small cap equities.
